| Patent application number | Description | Published |
|---|
| 20090097458 | Method and System for Agent Redirecting the Terminal Request - A method and system for agent redirecting the terminal request is provided. Firstly a uniform service address is preset for each service in the terminals. The terminal initiates a service access request. The agent gateway queries the service subscribing information of the user. The agent gateway determines the type of the service requested by the terminal according to the uniform service address and queries the address of the corresponding service server. The agent gateway transmits the service access request to the service server obtained by query. The service server returns the access response of the service to the terminal via the agent gateway. The present invention can choose the suitable service server and agent redirect the service access request to the designated service server in the case that multiple servers exist by presetting the uniform service address in the terminal. In the meantime, presetting the uniform service address in the terminal can avoid the complicated configuration process of the server address in the terminal and improve the service level for the users. | 04-16-2009 |
| 20090207816 | Method for Ensuring the Service Platform the Acquisition of the User Terminal Information Under Multiple Application Protocols - The present invention discloses a method for ensuring the service platform the acquisition of the user terminal information under multiple application protocols, wherein client terminal service connection software is set in the user terminal or the user card, and said client terminal service connection software has service connection user interface and is able to inspect and control the mobile service connection carried out by the mobile terminal. By adding the step of sending the general application protocol request to the proxy server before the service request of the user terminal, it is ensured that the service platform is still capable of acquiring the user's cellphone number without upgrading the proxy server, so that it avoids the problem of frequent upgrading for equipments caused by new application protocol's appearance, increases the adaptability to the upgrading of application protocols, decreases the network rebuilding cost, increases the flexibility of the management for terminals, and improves the service serving level and the user's feelings. | 08-20-2009 |
| 20090233591 | DATA SYNCHRONIZATION METHOD BETWEEN MOBILE TERMINAL AND SERVER - The present invention relates to a method of data uplink synchronization between a mobile terminal and a server. The server modifies the stored address book data one item by one item. The present invention also relates to a method of data downlink synchronization between a mobile terminal and a server. Before the server sends address book data to the mobile terminal requesting the downlink synchronization, it performs item-by-item adaptation of the address book data according to the item's attribute and parameter supported by the mobile terminal. The present invention relates to another method of data downlink synchronization between a mobile terminal and a server. The mobile terminal, according to the received address book data, modifies the stored address book one item by one item. The present invention implements the operation on each item in the address book, the adaptation to the item's attribute and parameter of the address book according to the specific situation of the mobile terminal, and the mapping to each item according to the meaning of the attribute and parameter so as to effectively avoid information loss caused by inconsistent attributes and parameters and the operations on the record. | 09-17-2009 |
| 20110214979 | REACTIVE DISTILLATION APPARATUS FOR A MULTISTAGE COUNTER-CURRENT ROTATING BED AND ITS APPLICATION - The present invention discloses a reactive distillation apparatus for multistage counter-current rotating bed and its application, the apparatus comprises a closed shell, in the center of which a revolving shaft linking each shell section is set, the said shaft is provided with two or more rotors in series connection, a feeding inlet, a reflux inlet and an outlet of the gas phase are mounted on the top end face of the shell while a waste liquid outlet and an inlet of the gas phase are set on the bottom end face of the shell, the said shell consists of an upper section of the shell and a lower section of the shell along the axial direction, the said rotor consists of a rotating disc firmly connecting with the revolving shaft and a static disc mounted to the shell, a group of concentric dynamic filler rings but with different diameters are installed at intervals along the radial direction, wherein the wall of the dynamic filler rings is holed, and the ring clearance between the dynamic filler rings is configured with static rings fastened on the static disc; the filler filled in the said dynamic filler ring includes a catalytic filler and a wire gauze filler with the catalyst filler filled in the dynamic filler ring of the outer circle of the upper rotor and the inner circle of the lower rotor and the wire gauze filler filled in the rest of the dynamic filler rings, to make the whole rotor structure equivalent to the distillation section, reactive distillation section and stripping section; a feeding inlet is arranged on the top cover of the shell corresponding to the spray nozzle of raw material liquid; a rotating liquid distributor is arranged on the inner side of the innermost dynamic filler ring of the said lower rotor. The catalyst of the present invention not only plays the role of catalytic reaction, but also increases the interphase mass transfer area; the present invention improves the mass transfer efficiency and the separation efficiency of the reactive distillation process. | 09-08-2011 |
| 20120144419 | INTERACTIVE TELEVISION - One or more techniques and/or systems are disclosed for interactive television. A desired contextual probability factor is identified for respective potential interactive content, such as stored in a database, based on information relating to a consumer context. Interactive contextual content is selectively activated to run concurrently with television programming running on a consumer display, where the activated contextual content is selected based on a desired consumer interest probability factor. When the consumer interacts with the contextual content a response is provided, comprising corresponding response information, which can be sent to a consumer device associated with interactive content. | 06-07-2012 |
| 20120258849 | Method of in situ synthesis by thermite reaction with sol-gel and FeNiCrTi/NiAl-A12O3 nanocomposite materials prepared by the method - The invention prepares FeNiCrTi/NiAl-A12O3 nanocomposite materials by a method of in situ synthesis by thermite reaction with sol-gel. The nanocomposite material has high intensity at high temperature, high tenacity at room temperature, good oxidation resistance and good resistance to thermal corrosion. The method of the invention comprises: igniting thermite mixture to produce a high temperature melt and putting the high temperature melt into a fast-cooling mold, thereby obtaining the FeNiCrTi/NiAl—Al | 10-11-2012 |
| 20130281438 | 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS - The invention relates to a novel class of 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as a FAK and/or Pyk2 inhibitor, to a process for their preparation, and to a composition thereof, as well as to use of the compounds for the inhibiting FAK and/or Pyk2 and method for the treatment of a FAK and/or Pyk2 mediated disorder or disease. | 10-24-2013 |
| 20130337533 | Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt - The present invention relates to a composition useful for the diagnosis of diseases associated with aberrant expression of the genes encoding the secreted proteins Futrin 1, 2, 3 and/or 4(=R-Spondin 2, 3, 1 and 4, respectively), e.g. in connection with tumors or diseases of the muscle, kidneys or bones. The present invention also relates to a pharmaceutical composition containing a compound which is capable of modifying (a) the expression of the gene encoding Futrin 1, 2, 3 and/or 4 or (b) the activity of the Futrin 1, 2, 3 and/or 4 protein. | 12-19-2013 |
| 20140134703 | Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt - The present invention relates to a composition useful for the diagnosis of diseases associated with aberrant expression of the genes encoding the secreted proteins Futrin 1, 2, 3 and/or 4 (=R-Spondin 2, 3, 1 and 4, respectively), e.g. in connection with tumors or diseases of the muscle, kidneys or bones. The present invention also relates to a pharmaceutical composition containing a compound which is capable of modifying (a) the expression of the gene encoding Futrin 1, 2, 3 and/or 4 or (b) the activity of the Futrin 1, 2, 3 and/or 4 protein. | 05-15-2014 |
| 20140186917 | Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt - The present invention relates to a composition useful for the diagnosis of diseases associated with aberrant expression of the genes encoding the secreted proteins Futrin 1, 2, 3 and/or 4(=R-Spondin 2, 3, 1 and 4, respectively), e.g. in connection with tumors or diseases of the muscle, kidneys or bones. The present invention also relates to a pharmaceutical composition containing a compound which is capable of modifying (a) the expression of the gene encoding Futrin 1, 2, 3 and/or 4 or (b) the activity of the Futrin 1, 2, 3 and/or 4 protein. | 07-03-2014 |
| 20140216300 | WATER-BASED INK FOR COMPUTER-TO-PLATE INKJET PRINTING AND PREPARATION METHOD THEREFOR - A water-based ink for use in a computer-to-plate inkjet printing and a preparation method therefor. A polymer of 5 to 40 wt %, an additive of 0.01 to 10 wt %, a dye or pigment of 0.01 to 10 wt %, an organic solvent of 1 to 30 wt %, an anti-foaming agent of 0 to 5 wt %, and deionized water are stirred and mixed at room temperature. When the polymer is dissolved, the mixed solution is filtered. The filtrate is the water-based ink. The water-based ink is sprayed via a computer-to-plate machine onto a surface of a metal substrate (which may be an aluminum plate, a zinc plate, or a copper plate) to form a graphic region. A printing plate allowing for computer-to-plate printing is acquired after solidification. The printing plate acquired is allowed to achieve a halftone dot reproduction rate between 2 and 99% and a recognition rate of 175 lpi. | 08-07-2014 |
| 20140302640 | FCoC (Flip Chip on Chip) Package and Manufacturing Method thereof - A manufacturing method for Flip Chip on Chip (FCoC) package based on multi-row Quad Flat No-lead (QFN) package is provided wherein the lower surface of plate metallic base material are half-etched to form grooves. Insulation filling material is filled in the half-etched grooves. The upper surface of plate metallic base material is half-etched to form chip pad and multi-row of leads. Encapsulating first IC chip, second IC chip, solder bumps, underfill material, and metal wire to form an array of FCoC package based on the type of multi-row QFN package. Sawing and separating the FCoC package array, and forming FCoC package unit. | 10-09-2014 |
| 20140357510 | Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt - The present invention relates to a composition useful for the diagnosis of diseases associated with aberrant expression of the genes encoding the secreted proteins Futrin 1, 2, 3 and/or 4 (=R-Spondin 2, 3, 1 and 4, respectively), e.g. in connection with tumors or diseases of the muscle, kidneys or bones. The present invention also relates to a pharmaceutical composition containing a compound which is capable of modifying (a) the expression of the gene encoding Futrin 1, 2, 3 and/or 4 or (b) the activity of the Futrin 1, 2, 3 and/or 4 protein. | 12-04-2014 |
